T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.47B |
| 2 |
NXP Semiconductors
NXPI
|
+$1.73B |
| 3 |
Tesla
TSLA
|
+$1.7B |
| 4 |
Northrop Grumman
NOC
|
+$1.67B |
| 5 |
Dollar Tree
DLTR
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.29B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.85B |
| 3 |
Texas Instruments
TXN
|
+$1.82B |
| 4 |
Microsoft
MSFT
|
+$1.27B |
| 5 |
Booking.com
BKNG
|
+$1.18B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.76% |
| 2 | Technology | 16.79% |
| 3 | Consumer Discretionary | 15.26% |
| 4 | Financials | 14.49% |
| 5 | Industrials | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
Magnolia Oil & Gas
MGY
$6.13B
| $52.2M | 0.01% |
3,477,369
+1,967,460
| +130% | +$25.7M |
|
902
Theravance Biopharma
TBPH
$878M
| $52.1M | 0.01% |
1,596,187
-144,593
| -8% | -$3.94M |
|
903
Middlesex Water
MSEX
$1.11B
| $52M | 0.01% |
1,073,597
+107,846
| +11% | +$4.92M |
|
|
PCH
904
DELISTED
PotlatchDeltic
PCH
| $51.8M | 0.01% |
1,264,934
-16,645
| -1% | -$786K |
|
|
LOMA
905
Loma Negra
LOMA
$1.11B
| $51M | 0.01% |
5,768,739
+399,400
| +7% | +$3.8M |
|
906
Brady Corp
BRC
$4.43B
| $50.3M | 0.01% |
1,149,619
+17,637
| +2% | +$701K |
|
907
Jacobs Solutions
J
$16.8B
| $50.1M | 0.01% |
791,712
-32,374
| -4% | -$1.9M |
|
908
EPAM Systems
EPAM
$5.24B
| $50.1M | 0.01% |
363,789
+10,530
| +3% | +$1.42M |
|
|
EGN
909
DELISTED
Energen
EGN
| $49.9M | 0.01% |
579,240
+20,018
| +4% | +$1.52M |
|
910
Pegasystems
PEGA
$5.51B
| $49.9M | 0.01% |
1,594,614
-9,476
| -0.6% | -$287K |
|
911
Lindblad Expeditions
LIND
$2.26B
| $49.8M | 0.01% |
3,349,700
-3,179
| -0.1% | -$45K |
|
912
Suncor Energy
SU
$76.5B
| $49.6M | 0.01% |
1,282,400
-82,044
| -6% | -$3.32M |
|
|
CBIO
913
Crescent Biopharma
CBIO
$618M
| $49.6M | 0.01% |
34,436
-39
| -0.1% | -$59K |
|
914
Univest Financial
UVSP
$1.19B
| $49.5M | 0.01% |
1,869,739
-41,527
| -2% | -$1.16M |
|
915
Cencora
COR
$59.2B
| $49.1M | 0.01% |
532,795
-62,436
| -10% | -$5.4M |
|
916
Zurn Elkay Water Solutions
ZWS
$8.41B
| $49M | 0.01% |
3,300,188
-80,092
| -2% | -$1.14M |
|
917
MacroGenics
MGNX
$259M
| $49M | 0.01% |
2,283,146
+47,175
| +2% | +$1.01M |
|
918
McKesson
MCK
$99.9B
| $48.9M | 0.01% |
368,825
-213,461
| -37% | -$27.8M |
|
919
Integer Holdings
ITGR
$4.25B
| $48.9M | 0.01% |
589,619
+128,966
| +28% | +$9.67M |
|
920
Oneok
OKE
$58.4B
| $48.9M | 0.01% |
720,782
-2,353
| -0.3% | -$161K |
|
921
Perdoceo Education
PRDO
$1.99B
| $48.7M | 0.01% |
3,263,112
-107,068
| -3% | -$1.77M |
|
|
NVRO
922
DELISTED
NEVRO CORP.
NVRO
| $48.2M | 0.01% |
845,526
+825,678
| +4,160% | +$51.6M |
|
923
TETRA Technologies
TTI
$1.25B
| $48.1M | 0.01% |
10,675,312
+676,036
| +7% | +$3.06M |
|
924
Emergent Biosolutions
EBS
$230M
| $48.1M | 0.01% |
730,762
+118,273
| +19% | +$6.9M |
|
|
MSGN
925
DELISTED
MSG Networks Inc.
MSGN
| $48.1M | 0.01% |
1,863,211
-38,521
| -2% | -$924K |
|
Similar funds
T. Rowe Price Associates's Q3 2018 Portfolio in Review
As of Q3 2018, T. Rowe Price Associates held 2,658 positions worth $685B, up 4.7% from $654B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
T. Rowe Price Associates's Q3 2018 filing shows 77 new, 1,268 increased, 1,098 reduced and 77 closed positions. Its largest new stake was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A: 194,161 shares worth $208M. The largest sale was Broadcom, an estimated $3.29B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2018 buy was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A: 194,161 shares worth $208M.
- T. Rowe Price Associates added most to NVIDIA in Q3 2018, an estimated $2.47B increase.
- T. Rowe Price Associates's biggest Q3 2018 reduction was Broadcom, cutting an estimated $3.29B.
- T. Rowe Price Associates fully exited DCT Industrial Trust Inc. in Q3 2018, selling an estimated $345M.
- T. Rowe Price Associates's ten largest holdings make up 20% of its $685B portfolio in Q3 2018.
- T. Rowe Price Associates opened 77 new positions and closed 77 in Q3 2018.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $685B.
Based on T. Rowe Price Associates's 13F filing for Q3 2018, filed 14 Nov 2018.